Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Mural Oncology plc before investing.

In this article, we go over a few key elements for understanding Mural Oncology plc’s stock price such as:

• Mural Oncology plc’s current stock price and volume
• Why Mural Oncology plc’s stock price changed recently
• Upgrades and downgrades for MURA from analysts
• MURA’s stock price momentum as measured by its relative strength

About Mural Oncology plc (MURA)

Before we jump into Mural Oncology plc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company’s lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

Want to learn more about Mural Oncology plc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Mural Oncology plc.

Mural Oncology plc’s Stock Price as of Market Close

As of May 21, 2025, 12:34 PM, CST, Mural Oncology plc’s stock price was $2.856.

Mural Oncology plc is down 4.17% from its previous closing price of $2.980.

During the last market session, Mural Oncology plc’s stock traded between $2.824 and $2.910. Currently, there are approximately 17.17 million shares outstanding for Mural Oncology plc.

Mural Oncology plc’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Mural Oncology plc Stock Price History

Mural Oncology plc’s (MURA) price is currently up 8.58% so far this month.

During the month of May, Mural Oncology plc’s stock price has reached a high of $2.980 and a low of $2.470.

Over the last year, Mural Oncology plc has hit prices as high as $4.740 and as low as $0.950. Year to date, Mural Oncology plc’s stock is down 11.32%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Mural Oncology plc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 20, 2025, there was 1 analyst who downgraded Mural Oncology plc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Mural Oncology plc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Mural Oncology plc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Mural Oncology plc’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Mural Oncology plc (MURA) by visiting AAII Stock Evaluator.

Relative Price Strength of Mural Oncology plc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 20, 2025, Mural Oncology plc has a weighted four-quarter relative price strength of -10.90%, which translates to a Momentum Score of 24 and is considered to be Weak.

Want to learn more about how Mural Oncology plc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Mural Oncology plc Stock Price: Bottom Line

As of May 21, 2025, Mural Oncology plc’s stock price is $2.856, which is down 4.17% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Mural Oncology plc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.